TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable…
Medical - Devices
US, Andover [HQ]
Cash Flow Statements
8 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Cash Flow (OCF) | -24.00 | -23.00 | -25.00 | -32.00 | -30.00 | -28.00 | -45.00 | -13.00 | |
| Operating Cash (Net) | -24.00 | -23.00 | -25.00 | -32.00 | -30.00 | -28.00 | -45.00 | -13.00 | |
| Accounts Receivable | - - | - - | -2.00 | -3.00 | - - | - - | -21.00 | -33.00 | |
| Accounts Payable | 1.00 | - - | - - | 3.00 | -5.00 | 5.00 | -3.00 | 6.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | |
| Change | - - | -2.00 | -4.00 | -1.00 | -5.00 | 3.00 | -26.00 | -44.00 | |
| Other WC | - - | - - | - - | 2.00 | 2.00 | 1.00 | 6.00 | 10.00 | |
| Investing Activities | |||||||||
| Used Cash (Net) | -39.00 | 24.00 | 12.00 | -60.00 | -41.00 | 29.00 | 54.00 | -193.00 | |
| Capital Expenditure | -1.00 | - - | - - | - - | - - | -3.00 | -11.00 | -179.00 | |
| Purchases of Investments | -46.00 | -19.00 | - - | -82.00 | -121.00 | -72.00 | -10.00 | - - | |
| Sale/Maturity of Investment | 8.00 | 44.00 | 12.00 | 22.00 | 80.00 | 104.00 | 76.00 | - - | |
| Property, Plant, Equipment (P&PE) | -1.00 | - - | - - | - - | - - | -3.00 | -11.00 | -179.00 | |
| Acquisitions (Net) | - - | - - | - - | 60.00 | 41.00 | -32.00 | - - | -14.00 | |
| Other Investing Activities | -38.00 | 25.00 | 12.00 | -60.00 | -41.00 | 32.00 | - - | -27.00 | |
| Financing Activities | |||||||||
| Used Cash (Net) | -63.00 | - - | -22.00 | -92.00 | -75.00 | -1.00 | -167.00 | -400.00 | |
| Debt Repayment | - - | - - | -9.00 | - - | -2.00 | - - | -22.00 | -393.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | 6 | |
| Issued | 63.00 | - - | - - | 97.00 | 75.00 | 1.00 | 145.00 | 7.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 63.00 | - - | 31.00 | -4.00 | 75.00 | 1.00 | 145.00 | -52.00 | |
| Cash Balances | |||||||||
| Begin of Period | 10.00 | 10.00 | 12.00 | 20.00 | 20.00 | 25.00 | 26.00 | 201.00 | |
| End of Period | 10.00 | 12.00 | 20.00 | 20.00 | 25.00 | 26.00 | 201.00 | 394.00 | |
| Change | - - | 2.00 | 8.00 | - - | 4.00 | - - | 175.00 | 193.00 | |
| Non-Cash Balances | |||||||||
| Depreciation and Amortization | - - | - - | - - | 1.00 | 1.00 | 1.00 | 3.00 | 8.00 | |
| Stock Based Compensation | - - | - - | - - | - - | 2.00 | 6.00 | 10.00 | 19.00 | |
| Other | - - | - - | - - | - - | - - | 1.00 | 3.00 | 29.00 | |
| Highlighted metrics | |||||||||
| Free Cash Flow (FCF) | -25.00 | -23.00 | -26.00 | -32.00 | -30.00 | -32.00 | -57.00 | -192.00 | |
| Cash Conversion Cycle (CCC) | - - | 337.00 | 324.00 | 250.00 | 532.00 | 400.00 | 331.00 | 227.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | -1.00 | - - |